Hosted on MSN1y
SoftBank-Backed Genetic Testing Invitae's Descent from $7B Valuation to Near-BankruptcyInvitae’s stock, which once soared above $50 ... approximately $90 million-100 million on an annualized basis. Price Action: NVTA shares are down 68.80% at $0.122 on the last check Monday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback